[Anti-arrhythmia effectiveness of potassium-magnesium-aspartate infusion].
In 21 patients with ventricular arrhythmias we analysed the effect of an intravenous infusion of potassium-magnesium-aspartate. It could be demonstrated that the frequency of ventricular ectopic beats significantly declined 1 hour after starting the medication. The maximum effect occurred at the 6th and 7th hour and continued until the 10th hour after starting the medication.
Kühn
P
P
II. Interne Abteilung, Barmherzige Schwester , Linz.
Oberthaler
G
G
Oswald
J
J
D000889:Anti-Arrhythmia Agents; D005117:Cardiac Complexes, Premature / Q000188:drug therapy*; D015716:Electrocardiography, Ambulatory / Q000187:drug effects* / Q000295:instrumentation; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008838:Microcomputers; D008875:Middle Aged; D011195:Potassium Magnesium Aspartate / Q000008:administration & dosage*; D012815:Signal Processing, Computer-Assisted / Q000295:instrumentation
D000889:Anti-Arrhythmia Agents; D011195:Potassium Magnesium Aspartate
Antiarrhythmische Wirksamkeit von Kalium-Magnesium-Aspartat-Infusion.